Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors.
about
Insulin resistance in patients with chronic kidney diseaseMitochondria: a new therapeutic target in chronic kidney diseasePredictors of Plaque Progression in Hypertensive Angina Patients with Achieved Low-Density Lipoprotein Cholesterol Less Than 70 mg/dL after Rosuvastatin Treatment.Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease.Suboptimal medical care of patients with ST-elevation myocardial infarction and renal insufficiency: results from the Korea Acute Myocardial Infarction Registry.Relation between mild to moderate chronic kidney disease and coronary artery disease determined with coronary CT angiography.Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs.The role of oxidative stress in menopause.Genetic polymorphism of ACE and the angiotensin II type1 receptor genes in children with chronic kidney diseaseConcomitant renal insufficiency and diabetes mellitus as prognostic factors for acute myocardial infarction.A randomized trial of intravenous and oral iron in chronic kidney diseaseAssociation of coronary artery disease and chronic kidney disease in Lebanese populationProtective effects of vitamin D3 on fimbrial cells exposed to catalytic iron damageSerum catalytic Iron: A novel biomarker for coronary artery disease in patients on maintenance hemodialysisThe Beneficial Effects of Renal Transplantation on Altered Oxidative Status of ESRD PatientsAttenuation of Na/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy.Moderate- to high-intensity statins for secondary prevention in patients with type 2 diabetes mellitus on dialysis after acute myocardial infarction.Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.Targeting Na/K-ATPase Signaling: A New Approach to Control Oxidative Stress.A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy.The Ratio of Plasma and Urinary 8-oxo-Gsn Could Be a Novel Evaluation Index for Patients with Chronic Kidney Disease.Valsartan Alleviates Insulin Resistance in Skeletal Muscle of Chronic Renal Failure Rats.Non-mercaptalbumin, Oxidized Form of Serum Albumin, Significantly Associated with Renal Function and Anemia in Chronic Kidney Disease Patients
P2860
Q21285003-AE04DF70-6F5D-4A8B-9851-855E25CECBE4Q26776397-3D5EB8F3-5BCE-483B-A9E9-B2B9C41AA003Q30394491-A3856DE8-3A07-4DB2-B15A-5F851A63206DQ33495688-16DCC91A-F8BC-4F5D-9682-4C3C7DDA10A4Q34411141-802DBEBC-9FBD-4120-B26E-3F632DA194BCQ34448133-C9ECF8F9-38F8-44B8-BE41-01F7C4EABA75Q34453236-CA77A57D-5344-4E39-B88F-F6B2DBBDF363Q35132577-FDFFD6FA-677D-4808-9C2B-A2F016962354Q35198662-2A8C3838-96D3-44F8-A5F1-C9593B84493BQ35576618-22875DDC-8EBA-43A8-87EB-13F31CA77A98Q36108862-4D0D870E-A2E0-4C89-9F90-764E10012F63Q36317731-932EEB36-D51C-4816-B0E5-3A3E7F63D58EQ37017956-5F2B6D03-E715-4E80-AAB3-643FCDD1BD48Q37150884-54C7DCB7-A153-4194-B1D5-43EECF9F309AQ37166294-A4909C61-6356-44BF-9ECB-AB80EEFD2F8DQ37307099-F7F31C06-F60A-4631-955D-7B5D3413D546Q41712924-BA377601-B38D-4A1D-A69C-B19A8206699CQ43692218-BFA0BED3-AB03-4232-A896-4110A1521BACQ50108231-F4877FF1-0FA5-4A1C-9752-CE62EE4BC3B3Q50204724-230CAEA0-B27B-41C1-A96A-44E2FC498137Q51244470-DBA4BF12-F078-4587-8390-CD47F838E9B0Q52717838-C1A2A877-6B9E-4F22-B370-A8B512A44521Q59127057-B9C892E6-A289-441D-8733-5FE9FA7E25D4
P2860
Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Reassessing the cardiac risk p ...... ditional cardiac risk factors.
@en
type
label
Reassessing the cardiac risk p ...... ditional cardiac risk factors.
@en
prefLabel
Reassessing the cardiac risk p ...... ditional cardiac risk factors.
@en
P2093
P1476
Reassessing the cardiac risk p ...... aditional cardiac risk factors
@en
P2093
Henrich WL
Himmelfarb J
P304
P577
1997-03-01T00:00:00Z